Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.

Clinical trials sponsored by Shanghai Yinnuo Pharmaceutical Technology Co., Ltd., explained in plain language.

Upcoming readouts

Trials from this sponsor expected to report results within the next 12 months.

New obesity drug shows promise for teens in early trial Results expected Apr 2027 (estimated)

Browse trials soon ready across all sponsors →

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1 Completed 1

New diabetes shot could cut injections in half

Disease control Completed

This study tested a new drug called efsubaglutide alfa in 59 adults with type 2 diabetes whose blood sugar was not well controlled by diet and exercise alone. Participants received either a 3mg injection every two weeks or a 1mg injection weekly for 12 weeks. The goal was to see …

Phase 2 • Sponsor: Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. • Aim: Disease control

Last updated Jun 26, 2026 15:54 UTC